Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi

Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on pe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2021-07, Vol.13 (14), p.3401
Hauptverfasser: Franceschetti, Silvia, Annunziata, Maria Antonietta, Agostinelli, Giulia, Gerardi, Chiara, Allocati, Eleonora, Minoia, Carla, Guarini, Attilio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 14
container_start_page 3401
container_title Cancers
container_volume 13
creator Franceschetti, Silvia
Annunziata, Maria Antonietta
Agostinelli, Giulia
Gerardi, Chiara
Allocati, Eleonora
Minoia, Carla
Guarini, Attilio
description Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.
doi_str_mv 10.3390/cancers13143401
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555103522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEolXbM1dLXLikdfyVLAekElpaKYDElnM0ccZZl8Re7CRo-Xv8sabbio_6YmveZ16NX02SvMroKecreqbBaQwx45nggmbPkkNGc5YqtRLP_3kfJCcx3tLlcJ7lKn-ZHHDBVoXK1GHyu4IRyWecgu99ZzX0BFxLSt85O9oZyRp_TNgD7suVd116g2Egn_yi-2BdR7whZQ8x7puvfNt9t45Uu2G78QPs2z5YY6aIpILQIXmfltj3f4n1FGY7-xDfknOy3sURBxitJl9xtviTNDsybpBcetfCL-sdkusRegsOSGWd8YM9Tl4Y6COePN5HybfLi5vyKq2-fLwuz6tU81Uxpko2hWSKAULOGs0NomlBAFUoGs6Nyg1lmZICluhQSNBCaamkEY0qtDT8KHn34LudmgFbjW4M0NfbYAcIu9qDrf9XnN3UnZ_rgtNcUbkYvHk0CH5JNY71YKNewgCHfoo1k1JmlEvGFvT1E_TWT8Et37unhFBcFnShzh4oHXyMAc2fYTJa3-9I_WRH-B3MG7Le</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554463580</pqid></control><display><type>article</type><title>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Franceschetti, Silvia ; Annunziata, Maria Antonietta ; Agostinelli, Giulia ; Gerardi, Chiara ; Allocati, Eleonora ; Minoia, Carla ; Guarini, Attilio</creator><creatorcontrib>Franceschetti, Silvia ; Annunziata, Maria Antonietta ; Agostinelli, Giulia ; Gerardi, Chiara ; Allocati, Eleonora ; Minoia, Carla ; Guarini, Attilio</creatorcontrib><description>Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.</description><identifier>ISSN: 2072-6694</identifier><identifier>EISSN: 2072-6694</identifier><identifier>DOI: 10.3390/cancers13143401</identifier><identifier>PMID: 34298616</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Anxiety ; B-cell lymphoma ; Bias ; Cancer therapies ; Cognitive ability ; Disease ; Fatigue ; Hodgkin's lymphoma ; Literature reviews ; Lymphocytes B ; Lymphoma ; Mental depression ; Neurological complications ; Neuropsychology ; Neurotoxicity ; Peripheral neuropathy ; Population ; Population studies ; Quality of life ; Stem cell transplantation ; Systematic Review ; Young adults</subject><ispartof>Cancers, 2021-07, Vol.13 (14), p.3401</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</citedby><cites>FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</cites><orcidid>0000-0002-5707-0689</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307605/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307605/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Franceschetti, Silvia</creatorcontrib><creatorcontrib>Annunziata, Maria Antonietta</creatorcontrib><creatorcontrib>Agostinelli, Giulia</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Allocati, Eleonora</creatorcontrib><creatorcontrib>Minoia, Carla</creatorcontrib><creatorcontrib>Guarini, Attilio</creatorcontrib><title>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</title><title>Cancers</title><description>Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.</description><subject>Anxiety</subject><subject>B-cell lymphoma</subject><subject>Bias</subject><subject>Cancer therapies</subject><subject>Cognitive ability</subject><subject>Disease</subject><subject>Fatigue</subject><subject>Hodgkin's lymphoma</subject><subject>Literature reviews</subject><subject>Lymphocytes B</subject><subject>Lymphoma</subject><subject>Mental depression</subject><subject>Neurological complications</subject><subject>Neuropsychology</subject><subject>Neurotoxicity</subject><subject>Peripheral neuropathy</subject><subject>Population</subject><subject>Population studies</subject><subject>Quality of life</subject><subject>Stem cell transplantation</subject><subject>Systematic Review</subject><subject>Young adults</subject><issn>2072-6694</issn><issn>2072-6694</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkk1v1DAQhiMEolXbM1dLXLikdfyVLAekElpaKYDElnM0ccZZl8Re7CRo-Xv8sabbio_6YmveZ16NX02SvMroKecreqbBaQwx45nggmbPkkNGc5YqtRLP_3kfJCcx3tLlcJ7lKn-ZHHDBVoXK1GHyu4IRyWecgu99ZzX0BFxLSt85O9oZyRp_TNgD7suVd116g2Egn_yi-2BdR7whZQ8x7puvfNt9t45Uu2G78QPs2z5YY6aIpILQIXmfltj3f4n1FGY7-xDfknOy3sURBxitJl9xtviTNDsybpBcetfCL-sdkusRegsOSGWd8YM9Tl4Y6COePN5HybfLi5vyKq2-fLwuz6tU81Uxpko2hWSKAULOGs0NomlBAFUoGs6Nyg1lmZICluhQSNBCaamkEY0qtDT8KHn34LudmgFbjW4M0NfbYAcIu9qDrf9XnN3UnZ_rgtNcUbkYvHk0CH5JNY71YKNewgCHfoo1k1JmlEvGFvT1E_TWT8Et37unhFBcFnShzh4oHXyMAc2fYTJa3-9I_WRH-B3MG7Le</recordid><startdate>20210707</startdate><enddate>20210707</enddate><creator>Franceschetti, Silvia</creator><creator>Annunziata, Maria Antonietta</creator><creator>Agostinelli, Giulia</creator><creator>Gerardi, Chiara</creator><creator>Allocati, Eleonora</creator><creator>Minoia, Carla</creator><creator>Guarini, Attilio</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TO</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5707-0689</orcidid></search><sort><creationdate>20210707</creationdate><title>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</title><author>Franceschetti, Silvia ; Annunziata, Maria Antonietta ; Agostinelli, Giulia ; Gerardi, Chiara ; Allocati, Eleonora ; Minoia, Carla ; Guarini, Attilio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-65b85262aea72bc3feefda4a06e4b33f67f021654a207e45ac46c565f4b68c5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anxiety</topic><topic>B-cell lymphoma</topic><topic>Bias</topic><topic>Cancer therapies</topic><topic>Cognitive ability</topic><topic>Disease</topic><topic>Fatigue</topic><topic>Hodgkin's lymphoma</topic><topic>Literature reviews</topic><topic>Lymphocytes B</topic><topic>Lymphoma</topic><topic>Mental depression</topic><topic>Neurological complications</topic><topic>Neuropsychology</topic><topic>Neurotoxicity</topic><topic>Peripheral neuropathy</topic><topic>Population</topic><topic>Population studies</topic><topic>Quality of life</topic><topic>Stem cell transplantation</topic><topic>Systematic Review</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Franceschetti, Silvia</creatorcontrib><creatorcontrib>Annunziata, Maria Antonietta</creatorcontrib><creatorcontrib>Agostinelli, Giulia</creatorcontrib><creatorcontrib>Gerardi, Chiara</creatorcontrib><creatorcontrib>Allocati, Eleonora</creatorcontrib><creatorcontrib>Minoia, Carla</creatorcontrib><creatorcontrib>Guarini, Attilio</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Franceschetti, Silvia</au><au>Annunziata, Maria Antonietta</au><au>Agostinelli, Giulia</au><au>Gerardi, Chiara</au><au>Allocati, Eleonora</au><au>Minoia, Carla</au><au>Guarini, Attilio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi</atitle><jtitle>Cancers</jtitle><date>2021-07-07</date><risdate>2021</risdate><volume>13</volume><issue>14</issue><spage>3401</spage><pages>3401-</pages><issn>2072-6694</issn><eissn>2072-6694</eissn><abstract>Background: The continuously improving treatment outcome for classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL) over the last 25 years has led to a high number of long-term survivors. The impact of treatment, however, can sometimes be dramatic and long-lasting. Focusing on peripheral neuropathy (PN), cognitive impairment, fatigue, anxiety, and depression, researchers of the Fondazione Italiana Linfomi conducted a systematic review of the literature to collect the available data on sequelae incidence as well as evidence of follow-up strategies for long-term cHL and DLBCL survivors. Methods: The review was carried out under the methodological supervision of the Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy. The literature search was conducted on three databases (MEDLINE, Embase, and the Cochrane Library) updated to November 2019. The selection process and data extraction were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A total of 2236 abstracts were screened, 247 full texts were analyzed, and 35 papers were included in the final analysis. Fatigue was the most extensively studied among neuropsychological sequelae, with a mean prevalence among cHL survivors of 10–43%. Although many of the papers showed an increased incidence of PN, cognitive impairment, and anxiety and depression in long-term cHL and DLBCL survivors, no definite conclusions can be drawn because of the methodological limitations of the analyzed studies. No data on monitoring and follow-up strategies of PN and other neuropsychological sequelae were highlighted. Conclusions: Based on our findings, future studies in this setting should include well-defined study populations and have a longitudinal trial design to assess the outcomes of interest over time, thus as to structure follow-up programs that can be translated into daily practice.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>34298616</pmid><doi>10.3390/cancers13143401</doi><orcidid>https://orcid.org/0000-0002-5707-0689</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2072-6694
ispartof Cancers, 2021-07, Vol.13 (14), p.3401
issn 2072-6694
2072-6694
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8307605
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Anxiety
B-cell lymphoma
Bias
Cancer therapies
Cognitive ability
Disease
Fatigue
Hodgkin's lymphoma
Literature reviews
Lymphocytes B
Lymphoma
Mental depression
Neurological complications
Neuropsychology
Neurotoxicity
Peripheral neuropathy
Population
Population studies
Quality of life
Stem cell transplantation
Systematic Review
Young adults
title Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A50%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20Neurological%20and%20Cognitive%20Sequelae%20and%20Long-Term%20Monitoring%20of%20Classical%20Hodgkin%20Lymphoma%20and%20Diffuse%20Large%20B-Cell%20Lymphoma%20Survivors:%20A%20Systematic%20Review%20by%20the%20Fondazione%20Italiana%20Linfomi&rft.jtitle=Cancers&rft.au=Franceschetti,%20Silvia&rft.date=2021-07-07&rft.volume=13&rft.issue=14&rft.spage=3401&rft.pages=3401-&rft.issn=2072-6694&rft.eissn=2072-6694&rft_id=info:doi/10.3390/cancers13143401&rft_dat=%3Cproquest_pubme%3E2555103522%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2554463580&rft_id=info:pmid/34298616&rfr_iscdi=true